Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37978284

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2024 Jan
First author
Kilburn LB

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2024 May;30(5):1500. doi: 10.1038/s41591-024-02910-1.
    note
    Source null
    related pmid
    38467878
    relationship
    Erratum in
  2. citation
    Nat Med. 2025 Jul;31(7):2454. doi: 10.1038/s41591-025-03709-4.
    note
    Source null
    related pmid
    40240838
    relationship
    Erratum in

Authors and identifiers

  1. name
    Kilburn LB
    type
    Author
  2. name
    Khuong-Quang DA
    type
    Author
  3. name
    Hansford JR
    type
    Author
  4. name
    Landi D
    type
    Author
  5. name
    van der Lugt J
    type
    Author
  6. name
    Leary SES
    type
    Author
  7. name
    Driever PH
    type
    Author
  8. name
    Bailey S
    type
    Author
  9. name
    Perreault S
    type
    Author
  10. name
    McCowage G
    type
    Author
  11. name
    Waanders AJ
    type
    Author
  12. name
    Ziegler DS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kilburn LB
    type
    Author
  2. name
    Khuong-Quang DA
    type
    Author
  3. name
    Hansford JR
    type
    Author
  4. name
    Landi D
    type
    Author
  5. name
    van der Lugt J
    type
    Author
  6. name
    Leary SES
    type
    Author
  7. name
    Driever PH
    type
    Author
  8. name
    Bailey S
    type
    Author
  9. name
    Perreault S
    type
    Author
  10. name
    McCowage G
    type
    Author
  11. name
    Waanders AJ
    type
    Author
  12. name
    Ziegler DS
    type
    Author
bibliography ids
  1. nci-bib-0b3c2e60b8d1e3b12a733f56
book metadata
content sha256
81edd4c5d0599760344cb0d718513f0a896c62a1365b81379224de3c5d644edf
document type
citation
dois
  1. 10.1038/s41591-023-02668-y
electronic publication date
display
2023 Nov 17
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37978284
immutable id
pubmed:37978284@81edd4c5d0599760344cb0d718513f0a896c62a1365b81379224de3c5d644edf
journal
abbreviation
Nat Med
issn electronic
1546-170X
issn print
1078-8956
issue
1
name
Nature medicine
nlm unique id
9502015
pages
207-217
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2024 May;30(5):1500. doi: 10.1038/s41591-024-02910-1.
    note
    Source null
    related pmid
    38467878
    relationship
    Erratum in
  2. citation
    Nat Med. 2025 Jul;31(7):2454. doi: 10.1038/s41591-025-03709-4.
    note
    Source null
    related pmid
    40240838
    relationship
    Erratum in
outcomes validated
false
pmid
37978284
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
e89377d1f386dbf1c67fdb9315b4f2fe923283dcc553d0c057e62081b528363a
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan
precision
month
year
2024
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37978284/
title
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Preserved source evidence · Not medical advice